Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Hunger

Showing results (141-150 of 346) with videos related to

Pageof 35
Sort By:
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
International Journal of Cancer|August 4, 2015
Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331Hannah-Rose Mitchell, Xiaomin Lu, Regina M Myers, et al.
Journal of Translational Medicine|October 12, 2018
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar)Sara Deola, Bella S Guerrouahen, Heba Sidahmed, et al.
Pediatric Blood & Cancer|December 30, 2017
Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group studyJulio C Barredo, Caroline Hastings, Xiamin Lu, et al.
Pediatric Blood & Cancer|February 15, 2022
SIOP Strategy 2021-2025: Cure for more, care for allKathy Pritchard-Jones, Julia M Challinor, Stephen P Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.
Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Blood|December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent Wood, David Wu, Beryl Crossley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2017
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupNaomi Winick, Meenakshi Devidas, Si Chen, et al.
Science (New York, N.Y.)|November 15, 2014
Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic elementMarc R Mansour, Brian J Abraham, Lars Anders, et al.
Pageof 35

Showing results (141-150 of 346) with videos related to

Sort By:
Pageof 35
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
International Journal of Cancer|August 4, 2015
Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331Hannah-Rose Mitchell, Xiaomin Lu, Regina M Myers, et al.
Journal of Translational Medicine|October 12, 2018
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar)Sara Deola, Bella S Guerrouahen, Heba Sidahmed, et al.
Pediatric Blood & Cancer|December 30, 2017
Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group studyJulio C Barredo, Caroline Hastings, Xiamin Lu, et al.
Pediatric Blood & Cancer|February 15, 2022
SIOP Strategy 2021-2025: Cure for more, care for allKathy Pritchard-Jones, Julia M Challinor, Stephen P Hunger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.
Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Blood|December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALLBrent Wood, David Wu, Beryl Crossley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2017
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupNaomi Winick, Meenakshi Devidas, Si Chen, et al.
Science (New York, N.Y.)|November 15, 2014
Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic elementMarc R Mansour, Brian J Abraham, Lars Anders, et al.
Pageof 35